期刊文献+

1745例Ⅱ、Ⅲ类切口手术患者使用PPI预防应激性溃疡的调查分析 被引量:12

Investigate the use of PPI to stress ulcer prophylaxis in 1 745 cases of surgical patients receiving aseptic-contaminative and contaminative incision operation
下载PDF
导出
摘要 目的评价Ⅱ、Ⅲ类切口手术患者使用质子泵抑制剂(PPI)预防应激性溃疡(SU)的合理性。方法抽取2013年1~4月外科住院的Ⅱ、Ⅲ类切口手术患者病历,对使用PPI预防SU的情况进行回顾性分析。结果共抽取病历1 745份,使用PPI预防SU的540例,总预防用药率为30.95%,其中ICU、普外科、泌尿科、胸外科和神经外科的总预防用药率高于其他科室(除外ICU、胸外科和神经外科与骨科);有高危因素232例,预防用药率为72.41%;无高危因素1 513例,预防用药率为24.59%,其中普外科、泌尿科和胸外科的无高危因素用药率高于其他科室(除外ICU、骨科与胸外科)。在预防SU的药物中,兰索拉唑的使用率高于奥美拉唑和泮托拉唑;术前预防用药率为14.44%,用药剂量过大的占0.93%,预防用药疗程过长的占12.78%。结论临床医生在使用PPI预防Ⅱ、Ⅲ类切口手术患者发生SU时,存在无高危因素用药、用药时机不恰当、疗程过长等现象。因此,需严格限制SU预防用药指征,规范PPI的合理使用。 Objective To study the rationality in the use of proton pump inhibitors (PPI) to stress ulcer(SU) prophylaxis in pa-tients receiving aseptic-contaminative and contaminative incision operation .Methods A retrospective analysis was performed on the use of PPI to SU ,which taken from surgical patients received aseptic-contaminative and contaminative incision operation and hospi-talized from January 2013 to April 2013 .Results Among 1 745 patients in the study ,540(30 .95% ) received a stress ulcer prophy-laxis with PPI .The rate of prophylaxis to ICU ,general surgery ,urology ,thoracic surgery and neurosurgery was higher than other departments(except for between ICU ,thoracic surgery ,neurosurgery and orthopedic) .A total of 232 patients had risk factors , 72 .41% of the patients who received prophylaxis .A total of 1 513 patients did not have risk factors ,24 .59% of the patients who received prophylaxis ,the rate of prophylaxis to general surgery ,thoracic surgery and urology was higher than other departments (except for ICU ,and between thoracic surgery with orthopedics ) .In prevention of SU ,the usage rate of Lansoprazole was higher than that of Omeprazole and Pantoprazole .Preoperative prophylactic usage rate was 14 .44% .Excessive dosage was 0 .93% .Preven-tive medicine treatment longer accounted for 12 .78% .Conclusion The phenomenon such as non-risk factors ,inappropriate of medi-cation time and long course of treatment are existed ,when physicians use the PPI for SU prophylaxis in surgical patients receiving aseptic-contaminative and contaminative incision operation .Therefore ,treatment recommendations for SU prophylaxis are needed to restrict PPI use for justified indications .
出处 《重庆医学》 CAS CSCD 北大核心 2014年第24期3212-3216,共5页 Chongqing medicine
关键词 清洁-污染 污染切口手术 应激性溃疡 质子泵抑制剂 aseptic-contaminative and contaminative incision operation stress ulcer proton pump inhibitor
  • 相关文献

参考文献18

  • 1Issa IA,Soubra O,Nakkash H,et al.Variables associatedwith stress ulcer prophylaxis misue:a retrospective analy-sis[J].Dig Dis Sci,2012,57(10):2633-2641.
  • 2Slattery E,Theyventhiran R,Cullen G,et al.Intravennous proton pump inhibitor use in hospital practice[J].Eur J Gastroenterol Hepatol,2007,19(6):461-464.
  • 3Grube RR,May DB.Stress ulcer prophylaxis in hospital-ized patients not in intensive care units[J].Am J Health Syst Pharm,2007,64(13):1396-1400.
  • 4Qadeer MA,Richter JE,Brotman DJ.Hospital-acquired gastrointestinal bleeding outside the critical care unit:risk factors,role of acid suppression,and endoscopy findings [J].J Hosp Med,2006,1(1):13-20.
  • 5李兆申.重视应激性溃疡的规范化防治[J].世界华人消化杂志,2005,13(22):2637-2639. 被引量:88
  • 6陈敏,黄敏.300例外科手术患者预防应激性溃疡药物调查[J].中国药师,2012,15(2):235-237. 被引量:12
  • 7Mohebbi L,Hesch K.Stress ulcer prophylaxis in the in-tensive care unit[J].Proc(Bayl Univ Med Cent),2009,22(4):373-376.
  • 8张增珠,李刚,陈集志,熊贤兵,王丹辉.质子泵抑制剂长期用药的临床风险[J].中国药物警戒,2013,10(11):663-665. 被引量:19
  • 9Jung R,Maclaren R.Proton-pump inhibitors for stress ul-cer prophylaxis in critically ill patients[J].Ann Pharma-cother,2002,36(12):1929-1937.
  • 10Hussain S,Stefan M,Visintainer P,et al.Why do physi-cians prescribe stress ulcer prophylaxis to general medi-cine patients[J].South Med J,2010,103(11):1103-1110.

二级参考文献90

共引文献182

同被引文献135

引证文献12

二级引证文献39

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部